Related Experiment Video
Updated: Jul 12, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Protein tyrosine phosphatase PTPN22 in human autoimmunity
Torkel Vang1, Ana V Miletic, Nunzio Bottini
1The Burnham Institute for Medical Research, La Jolla, CA 92037, USA.
Abstract:
The discovery that a single-nucleotide polymorphism (SNP) in lymphoid tyrosine phosphatase (LYP), encoded by the PTPN22 gene, is associated with type 1 diabetes (T1D) has now been verified by numerous studies and has been expanded to rheumatoid arthritis, juvenile rheumatoid arthritis (JRA), systemic lupus erythematosus, Graves' disease, generalized vitiligo and other human autoimmune diseases. In this paper, we discuss the association of PTPN22 with autoimmunity, the biochemistry of the PTPN22-encoded phosphatase, and the molecular mechanism(s) by which the disease-predisposing allele contributes to the development of human disease.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
